PVT1 and cancer: Interestingly, mRNA levels of these molecules decrease with PVT1 knockdown and increase with PVT1 overexpression (31, 64) PVT1 is implicated in DR and MDR in many cancer types, but further study is required to fully understand the pathways that mediate this PVT1-related cancer drug-resistance.